Homo sapiens Protein: C3
Summary
InnateDB Protein IDBP-21800.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol C3
Protein Name complement component 3
Synonyms AHUS5; ARMD9; ASP; C3a; C3b; CPAMD1; HEL-S-62p;
Species Homo sapiens
Ensembl Protein ENSP00000245907
InnateDB Gene IDBG-21798 (C3)
Protein Structure
UniProt Annotation
Function C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates.Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. In chronic inflammation, acts as a chemoattractant for neutrophils (By similarity). It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. {ECO:0000250}.C3-beta-c: Acts as a chemoattractant for neutrophils in chronic inflammation. {ECO:0000250}.Acylation stimulating protein: adipogenic hormone that stimulates triglyceride (TG) synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial TG clearance. Appears to stimulate TG synthesis via activation of the PLC, MAPK and AKT signaling pathways. Ligand for C5AR2. Promotes the phosphorylation, ARRB2-mediated internalization and recycling of C5AR2 (PubMed:8376604, PubMed:2909530, PubMed:9059512, PubMed:10432298, PubMed:15833747, PubMed:16333141, PubMed:19615750). {ECO:0000269PubMed:10432298, ECO:0000269PubMed:15833747, ECO:0000269PubMed:16333141, ECO:0000269PubMed:19615750, ECO:0000269PubMed:2909530, ECO:0000269PubMed:8376604, ECO:0000269PubMed:9059512}.
Subcellular Localization Secreted.
Disease Associations Complement component 3 deficiency (C3D) [MIM:613779]: A rare defect of the complement classical pathway. Patients develop recurrent, severe, pyogenic infections because of ineffective opsonization of pathogens. Some patients may also develop autoimmune disorders, such as arthralgia and vasculitic rashes, lupus-like syndrome and membranoproliferative glomerulonephritis. {ECO:0000269PubMed:7961791, ECO:0000269Ref.49}. Note=The disease is caused by mutations affecting the gene represented in this entry.Macular degeneration, age-related, 9 (ARMD9) [MIM:611378]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269PubMed:17634448, ECO:0000269PubMed:24036952}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]: An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. {ECO:0000269PubMed:18796626, ECO:0000269PubMed:20513133}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Other genes may play a role in modifying the phenotype.Note=Increased levels of C3 and its cleavage product ASP, are associated with obesity, diabetes and coronary heart disease. Short-term endurance training reduces baseline ASP levels and subsequently fat storage.
Tissue Specificity Plasma. The acylation stimulating protein (ASP) is expressed in adipocytes and released into the plasma during both the fasting and postprandial periods. {ECO:0000269PubMed:15833747, ECO:0000269PubMed:9555951}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 37 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 37 [view]
Protein-Protein 36 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004866 endopeptidase inhibitor activity
GO:0005102 receptor binding
GO:0005515 protein binding
GO:0031715 C5L2 anaphylatoxin chemotactic receptor binding
Biological Process
GO:0001798 positive regulation of type IIa hypersensitivity
GO:0001934 positive regulation of protein phosphorylation
GO:0001970 positive regulation of activation of membrane attack complex
GO:0006631 fatty acid metabolic process
GO:0006954 inflammatory response
GO:0006955 immune response
GO:0006956 complement activation
GO:0006957 complement activation, alternative pathway
GO:0006958 complement activation, classical pathway
GO:0007165 signal transduction
GO:0007186 G-protein coupled receptor signaling pathway
GO:0010575 positive regulation vascular endothelial growth factor production
GO:0010828 positive regulation of glucose transport
GO:0010866 regulation of triglyceride biosynthetic process
GO:0010884 positive regulation of lipid storage
GO:0010951 negative regulation of endopeptidase activity
GO:0030449 regulation of complement activation
GO:0045087 innate immune response (InnateDB)
GO:0045745 positive regulation of G-protein coupled receptor protein signaling pathway
GO:0045766 positive regulation of angiogenesis
GO:0050766 positive regulation of phagocytosis
GO:0050776 regulation of immune response
GO:2000427 positive regulation of apoptotic cell clearance
Cellular Component
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005886 plasma membrane
GO:0070062 extracellular vesicular exosome
GO:0072562 blood microparticle
Protein Structure and Domains
PDB ID
InterPro IPR000020 Anaphylatoxin/fibulin
IPR001134 Netrin domain
IPR001599 Alpha-2-macroglobulin
IPR001840 Anaphylatoxin, complement system domain
IPR002890 Alpha-2-macroglobulin, N-terminal
IPR008930 Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid
IPR008993 Tissue inhibitor of metalloproteinases-like, OB-fold
IPR009048 Alpha-macroglobulin, receptor-binding
IPR011625 Alpha-2-macroglobulin, N-terminal 2
IPR011626 Alpha-macroglobulin complement component
IPR018081 Anaphylatoxin, complement system
IPR018933 Netrin module, non-TIMP type
IPR019565 Alpha-2-macroglobulin, thiol-ester bond-forming
PFAM PF01821
PF00207
PF01835
PF07677
PF07703
PF07678
PF01759
PF10569
PRINTS PR00004
PIRSF
SMART SM00104
SM00643
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P01024
PhosphoSite PhosphoSite-P01024
TrEMBL V9HWA9
UniProt Splice Variant
Entrez Gene 718
UniGene Hs.529053
RefSeq NP_000055
HUGO HGNC:1318
OMIM 120700
CCDS CCDS32883
HPRD 00400
IMGT
EMBL AC008760 AY513239 BC150179 BC150200 CH471139 EU794602 K02765 M63423
GenPept AAA35722 AAA85332 AAI50180 AAI50201 AAR89906 ACJ13656 EAW69071